The Classical and Alternative Circulating Renin-angiotensin System in Normal Dogs and Dogs with Stage B1 and B2 Myxomatous Mitral Valve Disease

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2023 Mar 23

PMID 36951394

Authors

Hillary H Hammond

Marisa K Ames

Oliver Domenig

Brian A Scansen

Nuen Tsang Yang

Machelle D Wilson

Erin Sunshine

Kaitlyn Brunk

Allison Masters

Affiliations

Soon will be listed here.

Abstract

Background: The behavior of the comprehensive circulating renin-angiotensin system (RAS) in dogs with myxomatous mitral valve disease (MMVD) before to the onset of congestive heart failure remains largely unexplored.

Hypothesis/objectives: The classical and alternative RAS activity and aldosterone concentrations will be significantly higher in dogs with American College of Veterinary Internal Medicine (ACVIM) stage B2 MMVD compared to normal dogs and dogs with ACVIM stage B1 MMVD.

Animals: One-hundred seventeen client-owned dogs (normal = 60; B1 = 31; B2 = 26).

Methods: Prospective observational study. Angiotensin peptides (AP) and aldosterone concentrations were measured using liquid chromatography and mass spectrometry. Angiotensin converting enzymes 1 and 2 (ACE, ACE2) and renin activity surrogates were calculated from AP concentrations. Equilibrium dialysis (ED) and immediate protease inhibition (PI) methods of AP quantification were compared in 14 healthy dogs.

Results: Core RAS activity and aldosterone concentrations did not differ among the 3 groups. However, the balance between the alternative and classical RAS differed, with dogs with stage B2 MMVD having significantly higher ACE2 activity surrogate (ACE2 ) when compared to normal dogs (adjusted P = .02; ratio of medians for ACE2 [B2:normal], 1.89; 95% confidence interval [CI]: 1.4-2.6). The ED and PI methods of AP quantification were highly correlated (AngI, r = .9, P < .0001; AngII, r = .8, P = .001).

Conclusions And Clinical Importance: Circulating alternative RAS activity, specifically the surrogate measure of ACE2 activity, was increased in dogs with stage B2 MMVD as compared to normal dogs. Equilibrium dialysis results are analogous to immediate protease inhibition in dogs.

Citing Articles

Clinical studies in Myxomatous Mitral Valve Disease dogs: most prescribed ACEI inhibits ACE2 enzyme activity and ARB increases AngII pool in plasma.

Nair S, Hersh E, Margulies K, Daniell H Hypertens Res. 2025; .

PMID: 39837966 DOI: 10.1038/s41440-025-02109-y.

Plasma N-terminal pro-B-type natriuretic peptide and urinary aldosterone-to-creatinine ratio in healthy Chihuahuas.

Galizzi A, Dossi G, Pocar P, Borromeo V, Locatelli C BMC Vet Res. 2024; 20(1):501.

PMID: 39487514 PMC: 11529297. DOI: 10.1186/s12917-024-04344-w.

Effect of furosemide on comprehensive renin-angiotensin-aldosterone system activity of Thoroughbred horses.

Lehman M, Domenig O, Ames M, Morgan J J Vet Intern Med. 2024; 38(6):3272-3280.

PMID: 39434560 PMC: 11586568. DOI: 10.1111/jvim.17208.

Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease.

Murdoch J, Lourenco B, Berghaus R, Ames M, Hammond H, Coleman A J Vet Intern Med. 2024; 38(5):2535-2547.

PMID: 39206534 PMC: 11423453. DOI: 10.1111/jvim.17186.

Self-Reported Utilization of International (ACVIM Consensus) Guidelines and the Latest Clinical Trial Results on the Treatment of Dogs with Various Stages of Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners.

van Staveren M, Muis E, Szatmari V Animals (Basel). 2024; 14(5).

PMID: 38473157 PMC: 10930498. DOI: 10.3390/ani14050772.

References

Santos R, Sampaio W, Alzamora A, Motta-Santos D, Alenina N, Bader M . The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7). Physiol Rev. 2018; 98(1):505-553. PMC: 7203574. DOI: 10.1152/physrev.00023.2016. View

Lambert D, Yarski M, Warner F, Thornhill P, Parkin E, Smith A . Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem. 2005; 280(34):30113-9. PMC: 8062222. DOI: 10.1074/jbc.M505111200. View

Kobayashi M, Girerd N, Duarte K, Chouihed T, Chikamori T, Pitt B . Estimated plasma volume status in heart failure: clinical implications and future directions. Clin Res Cardiol. 2021; 110(8):1159-1172. DOI: 10.1007/s00392-020-01794-8. View

Friedrichs K, Harr K, Freeman K, Szladovits B, Walton R, Barnhart K . ASVCP reference interval guidelines: determination of de novo reference intervals in veterinary species and other related topics. Vet Clin Pathol. 2012; 41(4):441-53. DOI: 10.1111/vcp.12006. View

Coffman M, Guillot E, Blondel T, Garelli-Paar C, Feng S, Heartsill S . Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST). J Vet Intern Med. 2021; 35(4):1673-1687. PMC: 8295662. DOI: 10.1111/jvim.16155. View

Kvart C, Haggstrom J, Pedersen H, Hansson K, Eriksson A, Jarvinen A . Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation. J Vet Intern Med. 2002; 16(1):80-8. View

Zoufaly A, Poglitsch M, Aberle J, Hoepler W, Seitz T, Traugott M . Human recombinant soluble ACE2 in severe COVID-19. Lancet Respir Med. 2020; 8(11):1154-1158. PMC: 7515587. DOI: 10.1016/S2213-2600(20)30418-5. View

Ames M, Vaden S, Atkins C, Palerme J, Langston C, Grauer G . Prevalence of aldosterone breakthrough in dogs receiving renin-angiotensin system inhibitors for proteinuric chronic kidney disease. J Vet Intern Med. 2022; 36(6):2088-2097. PMC: 9708418. DOI: 10.1111/jvim.16573. View

Larouche-Lebel E, Loughran K, Oyama M, Solter P, Laughlin D, Sanchez M . Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease. J Vet Intern Med. 2019; 33(4):1571-1584. PMC: 6639469. DOI: 10.1111/jvim.15548. View

10.

Wang K, Gheblawi M, Nikhanj A, Munan M, MacIntyre E, ONeil C . Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries. Hypertension. 2021; 79(2):365-378. DOI: 10.1161/HYPERTENSIONAHA.121.18295. View

11.

Hammond H, Ames M, Domenig O, Scansen B, Yang N, Wilson M . The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease. J Vet Intern Med. 2023; 37(3):875-886. PMC: 10229370. DOI: 10.1111/jvim.16687. View

12.

Pavo N, Goliasch G, Wurm R, Novak J, Strunk G, Gyongyosi M . Low- and High-renin Heart Failure Phenotypes with Clinical Implications. Clin Chem. 2017; 64(3):597-608. DOI: 10.1373/clinchem.2017.278705. View

13.

Epelman S, Shrestha K, Troughton R, Francis G, Sen S, Klein A . Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail. 2009; 15(7):565-71. PMC: 3179261. DOI: 10.1016/j.cardfail.2009.01.014. View

14.

Hansson K, Haggstrom J, Kvart C, Lord P . Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement. Vet Radiol Ultrasound. 2002; 43(6):568-75. DOI: 10.1111/j.1740-8261.2002.tb01051.x. View

15.

Fox P . Pathology of myxomatous mitral valve disease in the dog. J Vet Cardiol. 2012; 14(1):103-26. DOI: 10.1016/j.jvc.2012.02.001. View

16.

Atkins C, Keene B, Brown W, Coats J, Crawford M, DeFrancesco T . Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Am Vet Med Assoc. 2007; 231(7):1061-9. DOI: 10.2460/javma.231.7.1061. View

17.

Cornell C, Kittleson M, Della Torre P, Haggstrom J, Lombard C, Pedersen H . Allometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med. 2004; 18(3):311-21. DOI: 10.1892/0891-6640(2004)18<311:asomcm>2.0.co;2. View

18.

Huh T, Larouche-Lebel E, Loughran K, Oyama M . Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease. J Vet Intern Med. 2020; 35(1):33-42. PMC: 7848384. DOI: 10.1111/jvim.15948. View

19.

Epelman S, Tang W, Chen S, Van Lente F, Francis G, Sen S . Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol. 2008; 52(9):750-4. PMC: 2856943. DOI: 10.1016/j.jacc.2008.02.088. View

20.

Bernay F, Bland J, Haggstrom J, Baduel L, Combes B, Lopez A . Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med. 2010; 24(2):331-41. DOI: 10.1111/j.1939-1676.2009.0467.x. View